Accession Number: | 0001209191-21-040079 |
Date: | 2021-06-09 |
Issuer: | PACIRA BIOSCIENCES, INC. (PCRX) |
Original Submission Date: |
BREGE LAURA
C/O PACIRA BIOSCIENCES, INC.
5 SYLVAN WAY, SUITE 300
PARSIPPANY, NJ 07054
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-09 | A | 1,066 | a | $0.00 | 8,987 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 60.96 | 2021-06-09 | deemed execution date | A | 7,626 (a) | 2022-06-09 | 2031-06-09 | common stock 7,626 | $60.96 | 7,626 | direct |
ID | footnote |
---|---|
f1 | represents restricted stock units that vest on june 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. |